Haibang Capital
37
12M
32
2.85
4
0.14
2
- Stages of investment
- Areas of investment
Summary
In 2011 was created Haibang Capital, which is appeared as VC. The main department of described VC is located in the Hangzhou. The company was established in Asia in China.
Among the most successful fund investment fields, there are Medical, Psychology. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Zylox, Zylox, IMPACT Therapeutics For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Haibang Capital, startups are often financed by Yueyin Venture Capital, WuXi Healthcare Ventures, Proxima Ventures Ltd. The meaningful sponsors for the fund in investment in the same round are Juren Capital, Highlight Capital, Yueyin Venture Capital. In the next rounds fund is usually obtained by SDIC Fund Management, Lilly Asia Ventures, Juren Capital.
The usual things for fund are deals in the range of 5 - 10 millions dollars. The important activity for fund was in 2015. The fund is constantly included in less than 2 investment rounds annually. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations.
The current fund was established by Gang Liang, Li Xie, Naxin Yao.
Investments analytics
Analytics
- Total investments
- 37
- Lead investments
- 4
- Exits
- 2
- Rounds per year
- 2.85
- Follow on index
- 0.14
- Investments by industry
- Health Care (11)
- Medical Device (9)
- Biotechnology (9)
- Medical (8)
- Manufacturing (8) Show 40 more
- Investments by region
-
- China (37)
- Peak activity year
- 2021
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.86
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| DECANS | 21 Feb 2022 | Manufacturing, Medical Device, Medical | Early Stage Venture | 77M | Zhejiang, Jiaxing, China |
| JH Cispoly | 22 Apr 2022 | Early Stage Venture | Beijing, Daxing, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.